|Articles|July 31, 2008
PharmTech Poll Results: Outsourced or In-house?
View the results of our poll on what services companies who outsource usually decide to keep in-house.
Advertisement
The question:
If your company uses contract service providers and manufacturers, which function(s) do you typically keep in-house?
Your responses:
- Discovery research (1 response)
- Preclinical animal research
- ADME-tox work
- Formulation development (1 response)
- Process development (1 response)
- Clincial-scale manufacturing through Phase I
- Clinical-scale manufacturing through Phase II
- Clinical-scale manufacturing through Phase III
- Clinical trials
- Scale-up to commercial manufacturing (2 responses)
- Commercial-scale manufacturing (2 responses)
- Fill-finish
- Other
Do you have any comments on this poll, or would you like to submit your vote? Email us at
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Syngene Extends Major Research Collaboration with BMS
2
PharmTech Weekly News Roundup – Week of January 12, 2026
3
The Impact of Patient-Centric Formulations on Service Providers
4
Sharp Expands European Injectable Packaging Capacity With €20 million Investment
5
